コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 n vitro) and a clinically important outcome (low birth weight).
2 terine environment (e.g., individuals with a low birth weight).
3 timality (viz foetal loss, preterm birth and low birth weight).
4 ll for gestational age, preterm delivery, or low birth weight).
5 rchidism and hypospadias are prematurity and low birth weight.
6 2 key perinatal outcomes, preterm birth and low birth weight.
7 elivery, intrauterine growth restriction and low birth weight.
8 ) has been associated with preterm birth and low birth weight.
9 are serious in terms of maternal anemia and low birth weight.
10 ons on maternal anemia, premature birth, and low birth weight.
11 impairment in 11-year-old children with very low birth weight.
12 strointestinal bleeding, or for infants with low birth weight.
13 significant reductions in preterm births and low birth weight.
14 but such alterations are not attributable to low birth weight.
15 ctions and those associated with prematurity/low birth weight.
16 itis with protein-losing enteropathy and had low birth weight.
17 s risk of hepatoblastoma was associated with low birth weight.
18 smoking during pregnancy is associated with low birth weight.
19 en gave birth to a baby that was preterm and low birth weight.
20 data regarding most of the risk factors for low birth weight.
21 omen would result in a reduced prevalence of low birth weight.
22 4, 2.9), respectively, in the probability of low birth weight.
23 ong pregnancies complicated by stillbirth or low birth weight.
24 ated with adverse pregnancy outcomes such as low birth weight.
25 pregnancy is very large, is associated with low birth weight.
26 nly statistically significant (P = 0.05) for low birth weight.
27 with maternal anemia, placental malaria, or low birth weight.
28 m at risk of adverse birth outcomes, such as low birth weight.
29 25 singleton full-term infants, 4 (3.2%) had low birth weights.
30 osocomial infections among infants with very low birth weights.
31 evidence that AgP in the mother predisposes low birth weights.
32 with nonsignificant decreases in the risk of low birth weight (0.68; .29-1.57) and fetal or neonatal
33 factors were 2.88 (95% CI, 2.28 to 3.63) for low birth weight, 1.54 (95% CI, 1.13 to 2.09) for matern
34 9.4%) preterm births, 95 (14.2%) births with low birth weight, 11 (1.7%) spontaneous abortions, and s
36 ; RR, 0.85; 95% CI, 0.80-0.91; P < .001) and low birth weight (40.2 vs 45.7 per 100 live births; RR,
38 tubes and faecal samples were analysed for a low-birth weight (725 g) neonate EGA 25 weeks in intensi
39 nce odds ratio, 1.15; 95% CI, 0.93 to 1.42), low birth weight (76 cases among 1768 exposed pregnancie
41 ociated with several complications including low birth weight, abnormal placentation and increased ri
42 imates were observed for the associations of low birth weight adjusted for gestational age at birth w
43 d significantly increased risks for neonatal low birth weight (adjusted relative risk [aRR] = 3.5; 95
47 who were born very preterm and/or with very low birth weight and 106 term-born control subjects from
50 tabolic diseases increase offspring risk for low birth weight and cardiometabolic diseases in adultho
52 n FGR for explaining the association between low birth weight and cardiovascular risk in adulthood.
53 he results show that the association between low birth weight and decreased cognitive ability has dec
54 to infants with risk factors, in addition to low birth weight and early gestational age, reduces the
55 Malaria during pregnancy is associated with low birth weight and increased perinatal mortality, espe
59 and fetal HLA-C variants are correlated with low birth weight and pre-eclampsia or high birth weight
63 ery (1792 vs. 7168), and birth of infants at low birth weight and small for gestational age (1784 vs.
67 difference (SD) in cognitive scores between low-birth-weight and normal-birth-weight children was la
68 legislation, 991 stillbirths, 5,470 cases of low birth weight, and 430 neonatal deaths were prevented
69 3.9% (95%CI 2.6-5.1; p < 0.001) reduction in low birth weight, and a 7.6% (95%CI 3.4-11.7; p = 0.001)
73 indirect causes of stillbirth, prematurity, low birth weight, and maternal and neonatal morbidity an
75 weeks, small and large for gestational age, low birth weight, and neonatal intensive care unit admis
77 of major congenital anomalies, prematurity, low birth weight, and small size for gestational age obs
80 ight and obese adolescents with a history of low birth weight are at even greater risk of developing
82 2.55, 95% CI = 1.04 to 2.65, and preterm and low birth weight as RR = 4.08, 95% CI = 1.55 to 10.76 in
83 nic-level PM2.5 levels and preterm birth and low birth weight at the individual level, adjusting for
85 s; however, prevention of preterm births and low-birth weight babies has a greater potential to impro
86 h cohort, despite a higher proportion of the low-birth-weight babies having a very low birth weight (
87 y 39 operations associated with 1 additional low birth weight baby, every 25 operations associated wi
88 h weight (<2500 g at birth), and preterm and low-birth-weight baby (<37 weeks of gestation and <2500
89 n had preterm delivery, 39 women delivered a low-birth-weight baby, and 22 women gave birth to a baby
90 perintensity volume on term MRI in extremely low birth weight (birth weight </=1000 g) survivors.
91 lementation in preterm (gestation <37 wk) or low-birth-weight (birth weight <2500 g) neonates was con
92 ease, neural tube defects, preterm birth and low birth weight, birth asphyxia, and intracranial hemor
93 h the largest PM2.5 range, preterm birth and low birth weight both were associated with the highest q
98 s-fostered to normally fed dams, demonstrate low birth weight, catch-up growth, and reduced life span
99 who were born very preterm and/or with very low birth weight, cBF volumes were significantly reduced
101 strabismus reported by the studies included low birth weight, cicatricial retinopathy of prematurity
102 Such a group comprises premature birth, low-birth-weight, congenital anomalies, perinatal asphyx
109 early parenteral nutrition (PN) in extremely low-birth-weight (ELBW) infants to promote growth and de
110 ed a retrospective cohort study of extremely low-birth-weight (ELBW; birth weight <1000 g) infants bo
111 alation is associated with preterm delivery, low birth weight, fetal growth retardation and developme
115 ormal birth weight, mothers of newborns with low birth weight had a 3-fold increased risk of VTE, whi
116 Both maternal smoking during pregnancy and low birth weight have been implicated in impaired develo
117 Adults who were born preterm with a very low birth weight have higher blood pressure and impaired
118 d morbidity (e.g., type 2 diabetes mellitus (low birth weight hazard ratio = 1.79, 95% confidence int
119 k of mortality (e.g., cardiac-related death (low birth weight hazard ratio = 2.69, 95% confidence int
120 eased risk of APOs such as preterm birth and low birth weight in a population-based study in rural In
122 r-age), wasting (low weight-for-height), and low birth weight in children aged between 0 and 59 mo at
123 pmol/L) was associated with a higher risk of low birth weight in newborns (adjusted risk ratio = 1.15
124 ciated with significantly increased risks of low birth weight in primigravidae (OR, 6.09; 95% CI, 1.1
125 er factors associated with preterm birth and low birth weight included treatment with chemotherapy an
126 r population-based twin cohort revealed that low birth weight increased the risk for development of I
127 deletion phenotype including the persistent low birth weight, increased body weight gain in early ad
128 how that mice lacking Snord116 globally have low birth weight, increased body weight gain, energy exp
129 , 0.90; 95% CI, 0.66 to 1.25), delivery of a low-birth-weight infant (4.1% and 3.7%; prevalence odds
135 dence of effect modification by inclusion of low birth weight infants (p=0.367) and no difference in
137 n volumes were markedly reduced in extremely low birth weight infants as compared to term newborns (r
139 support by nurses have higher rates of very low birth weight infants discharged home on human milk.
140 between the dependent variable (rate of very low birth weight infants discharged on "any human milk")
141 GC) therapy, while approximately 19% of very low birth weight infants receive postnatal GC therapy.
144 r disease, necrotizing enterocolitis in very low birth weight infants, and hepatic encephalopathy.
145 ntion of IC has become a major focus in very low birth weight infants, with fluconazole increasingly
147 0-3999 g), while the admission rate for very low-birth-weight infants (<1500 g) was 844.1 per 1000 li
148 uble-blind randomized clinical trial in very low-birth-weight infants (birth weight <1500 g) admitted
150 yielded similar short-term outcomes in very low-birth-weight infants regarding safety and efficacy w
153 k of bronchopulmonary dysplasia in extremely-low-birth-weight infants, clinicians attempt to minimize
162 ligodendrocytes, in preterm babies with very low birth weight is associated with decreased cerebral a
165 ter in life, and animal studies suggest that low birth weight is associated with reduced activity and
167 associated with disparities in the rates of low birth weight (LBW) and preterm birth (PTB) between w
168 uring pregnancy with preterm birth (PTB) and low birth weight (LBW) but disagree over which time fram
170 mum in aerodynamic diameter (PM2.5) and term low birth weight (LBW) have resulted in inconsistent fin
171 xposure data sources to examine odds of term low birth weight (LBW) in Los Angeles, California, women
172 India, and although this has been linked to low birth weight (LBW) in these populations, the relatio
175 ight was 2.44 +/- 0.42 kg, the prevalence of low birth weight (LBW) was 54.4%, and that of small-for-
176 Associations between exposures and risk of low birth weight (LBW) were adjusted by family and indiv
177 and the effectiveness of IPTp-SP at reducing low birth weight (LBW) were assessed among human immunod
178 ond-hand smoke (SHS) during pregnancy causes low birth weight (LBW), but its mechanism remains unknow
179 ted increased levels of these cytokines with low birth weight (LBW), especially for malaria-infected
180 ersity during pregnancy and maternal anemia, low birth weight (LBW), preterm birth (PTB), and stillbi
186 factors according to presence or absence of low birth weight (LBW, birth weight <2500 g), adjusted C
187 vestigated sex-specific associations between low birth weight (LBW; <2.5 kg) and adult-onset diabetes
188 studies have reported that individuals with low birth weights (LBW, <2500 g) have a lower intelligen
190 onspecific effects; early BCG vaccination of low-birth-weight (LBW) newborns reduces neonatal mortali
191 gestation), pregnancy-induced hypertension, low birth weight (< 2,500 g), and birth weight (grams) a
193 remature birth in conjunction with extremely low birth weight (<1 kg, ELBW) is associated with insuli
194 of the low-birth-weight babies having a very low birth weight (<1,500 g) in the more recent birth coh
195 at birth independently increases the risk of low birth weight (<2,500 g) and preterm birth (<37 weeks
196 weeks of gestation) was 6.7% (P = 0.113) and low birth weight (<2,500 g) was 10.2% (P = 1.00).
198 : preterm delivery (<37 weeks of gestation), low birth weight (<2500 g at birth), and preterm and low
200 reterm birth (gestational age <37 weeks) and low birth weight (<2500 g) with childhood asthma outcome
201 utcome measures included induction of labor, low birth weight (<2500 g), cesarean section, Apgar scor
203 on on birth weight and secondary outcomes of low birth weight (<2500 g), small for gestational age, b
207 r controlling for known modifiers, including low birth weight, maternal education, seizure disorder,
209 birth weight (VLBW, 1000-1499 g), moderately low birth weight (MLBW, 1500-2499 g) and NBW individuals
211 n (n = 224), preterm birth (n = 3,613), term low birth weight (n = 918), term small-for-gestational-a
212 244 postpartum females: mothers with preterm/low-birth weight newborns (n = 91 cases) and mothers wit
214 with preterm birth, but was associated with low birth weight [odds ratio (OR) = 1.22; 95% CI: 1.07,
215 nal protein restriction was used to generate low-birth-weight offspring that underwent accelerated po
216 lationship between advanced maternal age and low birth weight or preterm birth is statistically and s
217 ot independently associated with the risk of low birth weight or preterm delivery among mothers who h
218 95% CI, 1.25-1.94; 14 studies; I2, 39%) and low birth weight (OR, 1.96; 95% CI, 1.24-3.10; 8 studies
219 (odds ratio [OR], 2.45; 95% CI, 1.36-4.40), low birth weight (OR, 3.41; 95% CI, 1.61-7.26), and use
220 erm birth (OR: 2.36; 95% CI: 1.54-3.62), and low birth weight (OR: 2.00; 95% CI: 1.24-3.23) were foun
221 nce of the polymorphism on parasite density, low birth weight, or preterm delivery was discernible.
228 alence ratio [PR], 1.52; 95% CI, 1.34-1.71), low birth weight (PR, 1.59; 95% CI, 1.38-1.83), and cesa
232 multicentered clinical trial found that very low-birth weight preterm infants given bovine lactoferri
234 e-blind, randomized controlled study of very-low-birth-weight preterm neonates randomly allocated on
236 low Apgar score, small for gestational age, low birth weight, preterm birth, and neonatal infections
237 after adjusting for sex, parental education, low birth weight, preterm birth, parental social class,
239 orticosteroid exposure with orofacial cleft, low birth weight, preterm delivery, fetal death, low Apg
240 ax increases also reduced the risk of having low-birth-weight, preterm, and small-for-gestational-age
241 = 1.99; CI: 1.06, 3.72 for preterm birth and low birth weight, respectively, for PM2.5 >/= 36.5 mug/m
244 ning (SRP) in reducing the preterm-birth and low-birth-weight risks to analyze important subgroups an
245 95% confidence interval (CI) = 1.29 to 7.38, low birth weight RR = 2.55, 95% CI = 1.04 to 2.65, and p
246 BMIZ (+0.21; P = 0.035) and a lower risk of low birth weight (RR: 0.61, 95% CI: 0.39, 0.96; P = 0.03
247 psia, stroke, stillbirth, preterm birth, and low birth weight; screening and risk prediction test per
248 ailable evidence taken together, the risk of low birth weight seems to correlate with the quantity of
249 ease in adulthood, fathers of offspring with low birth weight should display an unfavorable profile o
250 There were no significant differences in low birth weight, small for gestational age, birth lengt
253 .40; P < 0.01] and reducing the incidence of low birth weight (SMD: -0.22; 95% CI: -0.37, -0.06; P <
254 se reproductive/developmental effects, e.g., low birth weight, spontaneous abortion, stillbirth, and
255 though genetics, maternal undernutrition and low birth weight status certainly play a role in child g
259 te that early vascular dysfunction occurs in low-birth-weight subjects, especially preterm (PT) infan
260 have an increased risk of preterm birth and low birth weight, suggesting that additional surveillanc
261 tion of patent infections at enrollment with low birth weight suggests the importance of preventing P
262 ly reported that the transition of extremely low-birth-weight survivors (</=1000 g) in their mid-20s
263 2011, and August 13, 2013, among 100 of 165 low-birth-weight survivors (60.6%) prematurely born betw
265 rticipants included 100 (39 males) extremely low-birth-weight survivors and 89 (33 males) normal-birt
266 cental villous volume, and contribute to the low birth weight that typifies high-altitude populations
267 othetical intervention where no infants were low birth weight, the adjusted controlled direct effect
268 dence linking prenatal stress, manifested by low birth weight, to metabolic syndrome and its individu
273 infants born very preterm (VPT) or with very low birth weight (VLBW) is necessary to guide clinical m
277 emely low birth weight (ELBW, <1000 g), very low birth weight (VLBW, 1000-1499 g), moderately low bir
278 s represent a high-risk subgroup of the very low-birth-weight (VLBW) (<1500 g) population that would
281 f antibiotic use among all hospitalized very low-birth-weight (VLBW) infants across Canada and the as
282 typically benign in term infants but in very low-birth-weight (VLBW) infants can cause pneumonitis an
285 tiation of parenteral lipid infusion to very-low-birth-weight (VLBW) infants varies widely among diff
289 udy from January 2010 to February 2014, very low-birth-weight (VLBW, </=1500 g) infants, within 5 day
290 ons are commonly present in preterm and very low-birth-weight (VLWB) infants and might contribute to
293 who were born very preterm and/or with very low birth weight was specifically associated with both n
294 to maternal smoking during uterine life and low birth weight were independently associated with havi
295 All adverse perinatal circumstances except low birth weight were more prevalent among women abused
297 sis showed a significantly increased risk of low birth weight when the dispensed amount of potent or
299 syndrome is an imprinting disorder involving low birth weight with complex genetics and diagnostics.
300 ons of maternal smoking during pregnancy and low birth weight with retinal nerve fiber layer (RNFL) t
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。